Screening, monitoring, and treatment framework for focused ultrasound
US-2024412845-A1 · Dec 12, 2024 · US
US9566454B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9566454-B2 |
| Application number | US-73868207-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 23, 2007 |
| Priority date | Sep 18, 2006 |
| Publication date | Feb 14, 2017 |
| Grant date | Feb 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method and system for non-ablative acne treatment and prevention is disclosed. The method utilizes ultrasound energy which is targeted at a region of interest to treat existing acne and prevent future acne from forming. The application of ultrasound energy causes numerous physiological effects that treat acne. Some of these physiological effects comprise reducing sebum, increasing perfusion at the region of interest, denaturing proteins at the region of interest, creating an uninhabitable environment at the region of interest, initiating programmed cell death at the region of interest and the initiation of mechanical effects at the region of interest.
Opening claim text (preview).
What is claimed is: 1. A method for treating acne in a skin of a subject, the method comprising: a) identifying a sebaceous gland in a portion of the skin having the acne with ultrasound imaging; and b) delivering an ultrasound energy from a transducer probe to the sebaceous gland, the ultrasound energy configured to generate an elevated temperature in the sebaceous gland for a predetermined length of time, wherein the predetermined length of time allows a decrease of sebum and sebum production and does not allow ablation or coagulation of tissue within the sebaceous gland at the elevated temperature to treat existing acne and prevent future acne from developing. 2. The method according to claim 1 , wherein the elevated temperature is in a range of 35° C. to 60° C. 3. The method according to claim 1 , wherein the elevated temperature is greater than 50° C. and the predetermined length of time is greater than five seconds. 4. The method according to claim 1 , wherein the elevated temperature and the predetermined length of time correspond to a thermal dose of less than one second at 56° C. 5. The method according to claim 1 , wherein the sebaceous gland is located at a depth below a surface of the skin in a range of 1 millimeter to 10 millimeters and the ultrasound energy is delivered to the depth. 6. The method according to claim 1 , wherein the ultrasound energy is focused ultrasound energy. 7. The method according to claim 6 , the method further comprising moving a focal depth of the focused ultrasound energy to a different focal depth during the delivering the ultrasound energy of step b). 8. A method for treating acne in a skin of a subject, the method comprising: a) identifying a pilosebaceous tissue in a portion of the skin having the acne with ultrasound imaging, the pilosebaceous tissue containing at least one bacterium associated with the acne; and b) delivering an ultrasound energy from a transducer probe to the pilosebaceous tissue, the ultrasound energy configured to generate an elevated temperature in the pilosebaceous tissue for a predetermined length of time, wherein the predetermined length of time initiates programmed cell death in the at least one bacterium and does not allow ablation or coagulation of tissue within the pilosebaceous tissue at the elevated temperature to treat existing acne and prevent future acne from developing. 9. The method according to claim 8 , wherein the elevated temperature is in a range of 35° C. to 60° C. 10. The method according to claim 8 , wherein the elevated temperature is greater than 50° C. and the predetermined length of time is greater than five seconds. 11. The method according to claim 8 , wherein the elevated temperature and the predetermined length of time correspond to a thermal dose of less than one second at 56° C. 12. The method according to claim 8 , wherein the pilosebaceous tissue is located at a depth below a surface of the skin in a range of 1 millimeter to 10 millimeters and the ultrasound energy is delivered to the depth. 13. The method according to claim 8 , wherein the ultrasound energy is focused ultrasound energy. 14. The method according to claim 13 , the method further comprising moving a focal depth of the focused ultrasound energy to a different focal depth during the delivering the ultrasound energy of step b). 15. The method according to claim 8 , wherein the at least one bacterium includes Propionibacterium acnes. 16. A method for treating acne in a skin of a subject, the method comprising: a) identifying a pilosebaceous tissue in a portion of the skin having the acne with ultrasound imaging; b) delivering an unfocused ultrasound energy from a transducer probe to the pilosebaceous tissue; c) sensing, using a sensor configured to sense an amount of ultrasound energy transferred to the pilosebaceous tissue, an amount of the unfocused ultrasound energy transferred to the pilosebaceous tissue; and d) in response to sensing that the amount of the unfocused ultrasound energy transferred to the pilosebaceous tissue has exceeded a predetermined threshold, stopping the delivering the unfocused ultrasound energy, wherein the predetermined threshold allows a physiological effect in the pilosebaceous tissue and does not allow ablation and coagulation of tissue within the pilosebaceous tissue to treat existing acne and prevent future acne from developing, wherein the physiological effect is selected from the group consisting of: increased blood perfusion; denaturing of proteins; inhibition of sebum production; and programmed cell death. 17. The method of claim 16 , wherein the predetermined threshold corresponds to a temperature in the pilosebaceous tissue of greater than 50° C. for a length of time of more than five seconds. 18. The method of claim 16 , wherein the predetermined threshold corresponds to a thermal dose of less than one second at 56° C. 19. The method of claim 16 , wherein the unfocused ultrasound energy is defocused ultrasound energy. 20. The method of claim 16 , the method further comprising: e) subsequent to step d), waiting a predetermined length of time to allow a temperature in the pilosebaceous tissue to lower; and f) repeating steps b), c), and d).
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Antiseborrheics · CPC title
Anti-acne agents · CPC title
using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.